PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.380
-0.010 (-0.23%)
At close: Jan 16, 2026, 4:00 PM EST
4.370
-0.010 (-0.23%)
After-hours: Jan 16, 2026, 5:16 PM EST
PolyPid Market Cap
PolyPid has a market cap or net worth of $72.69 million as of January 16, 2026. Its market cap has increased by 239.20% in one year.
Market Cap
72.69M
Enterprise Value
58.24M
1-Year Change
239.20%
Ranking
Category
Stock Price
$4.38
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $72.69M, a decrease of -11.81%. That is a compound annual growth rate of -2.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 73.03M | 1.15% |
| Dec 31, 2025 | 72.19M | 249.06% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 955.89B |
| Johnson & Johnson | 522.79B |
| AbbVie | 387.16B |
| UnitedHealth Group | 305.92B |
| AstraZeneca | 299.25B |
| Novartis AG | 272.12B |
| Merck & Co. | 272.08B |
| Novo Nordisk | 265.30B |